DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM).

Ajay K Nooka, Keith Stockerl-Goldstein, Hang Quach, Adam Forbes, Maria-Victoria Mateos, Amit Khot, Alan Tan, Rafat Abonour, Bikramjit Chopra, Rachel Rogers, Geraldine Ferron-Brady, Jacqueline Davidge, Steve Frey, Anne Yeakey, Mala Talekar, Katarina Luptakova, Ira Gupta, Rakesh Popat